Sleep

Upper airway stimulation was initially shown to be effective in adults with obstructive sleep apnea.

The VersiPD Cycler System is expected to be available in the US in 2022.

Investigators hypothesize that the development of culturally tailored interventions could prove beneficial for engaging racial and ethnic minority patients with data-driven insomnia treatment.

New data suggests that symptoms of depression are screened in addition to symptoms of insomnia in affected patients.

About 1 in 5 recent novel drug approvals were based on data extrapolated to a broader patient population or in regard to a concomitant drug use, including the controversial aducanumab indication from 2021.

Students who reported maltreatment had 2.47 times the odds of receiving an insomnia diagnosis than those without adverse childhood experiences.

Investigators found that sleep apnea was also associated with an increased risk of Parkinsons disease.

An association between REM-OSA and intima thickness was also observed in women patients.

Conversely, insomnia was associated with an increased risk of prostate cancer.

Dr. Ruth Benca details the newest findings from the Wake Up America: The Night & Day Impact of Insomnia survey.

The prevalence of short and long sleep duration were considerably higher among Black individuals during the 15-year study period.

New data shows that FT218 demonstrated clinically meaningful improvements regarding disrupted nighttime sleep compared to placebo in adults with narcolepsy.

The survey – the largest of its kind- found that 70% of people with trouble sleeping or insomnia reported being “desperate to find a solution”.

The use and legalization of cannabis products has been increasing in the US for a variety of medical concerns. Investigators aim to better understand the risks and benefits of owning a medical marijuana card.

The hope is society learns some of the lessons from the Cold War to better help patients with mental health concerns.

Social media has had an influence on the mental health toll the war in the Ukraine is having.

A new post-hoc analyses for the sodium oxybate FT218 found that the therapy improved daytime sleepiness, sleep quality, and refreshing nature of sleep in patients with narcolepsy.

Digital cognitive behavioral therapy for insomnia was the better option to patient education on all ratings for patients with self-reported morning or intermediate chronotypes.

New data on FT218 will be presented at the World Sleep 2022 conference in Rome.

Patients with obstructive sleep apnea had higher levels of inflammatory biomarkers of IL-6, TNF-α, and hsCRP levels compared to the control group.

The results of meta-analysis showed that telemedicine methods were more effective in treating chronic insomnia than in-person methods.

Dr. Avidan speaks of the increased prevalence of insomnia and sleep-wake patterns and promising new therapies for sleep disorders including narcolepsy.

Consistent quantitative evidence of sleep disturbance in this population has been associated with staff distress, resident agitation, and prescription of psychotropic medications.

Dr. Garcia-Molina speaks to how smart bed technology can unobtrusively collect data to predict and track the development of symptoms associated with respiratory illnesses.